NIH-NIAID, Laboratory of Malaria and Vector Research, Rockville, MD, USA.
NIH-NIAID, Research Technologies Branch, Bethesda, MD, USA.
Commun Biol. 2024 May 27;7(1):649. doi: 10.1038/s42003-024-06351-x.
Salivary complement inhibitors occur in many of the blood feeding arthropod species responsible for transmission of pathogens. During feeding, these inhibitors prevent the production of proinflammatory anaphylatoxins, which may interfere with feeding, and limit formation of the membrane attack complex which could damage arthropod gut tissues. Salivary inhibitors are, in many cases, novel proteins which may be pharmaceutically useful or display unusual mechanisms that could be exploited pharmaceutically. Albicin is a potent inhibitor of the alternative pathway of complement from the saliva of the malaria transmitting mosquito, Anopheles albimanus. Here we describe the cryo-EM structure of albicin bound to C3bBb, the alternative C3 convertase, a proteolytic complex that is responsible for cleavage of C3 and amplification of the complement response. Albicin is shown to induce dimerization of C3bBb, in a manner similar to the bacterial inhibitor SCIN, to form an inactive complex unable to bind the substrate C3. Size exclusion chromatography and structures determined after 30 minutes of incubation of C3b, factor B (FB), factor D (FD) and albicin indicate that FBb dissociates from the inhibited dimeric complex leaving a C3b-albicin dimeric complex which apparently decays more slowly.
唾液补体抑制剂存在于许多血液摄食节肢动物物种中,这些物种负责传播病原体。在摄食过程中,这些抑制剂阻止前炎症过敏毒素的产生,否则过敏毒素的产生可能干扰摄食,并限制膜攻击复合物的形成,否则复合物可能会损伤节肢动物肠道组织。在许多情况下,唾液抑制剂是新型蛋白质,可能具有药用价值或表现出可被药用开发的不寻常机制。Albicin 是来自传播疟疾的蚊子 Anopheles albimanus 的唾液中的补体替代途径的有效抑制剂。在这里,我们描述了 Albicin 与 C3bBb(替代 C3 转化酶)结合的冷冻电镜结构,该酶是负责切割 C3 和放大补体反应的蛋白水解复合物。Albicin 诱导 C3bBb 的二聚化,以类似于细菌抑制剂 SCIN 的方式形成无活性的复合物,无法结合底物 C3。凝胶过滤层析和 30 分钟孵育 C3、因子 B(FB)、因子 D(FD)和 Albicin 后确定的结构表明,FBb 从抑制的二聚复合物中解离,留下一个 C3b-Albicin 二聚复合物,显然其衰减更慢。